[stock_market_widget type="clock-markets" template="analog" timezone="America/New_York" title="New York" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/London" title="London" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/Brussels" title="Brussels" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Hong_Kong" title="Hong Kong" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Tokyo" title="Tokyo" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Australia/Sydney" title="Sydney" style="font-size: 7px; width: 100px;"]

Stock Market News

Novo Holdings completes $16.5 billion takeover of Catalent

12/18/2024

Less than a minute

2024.12.18 09:10

(Reuters) – Novo Holdings has completed its $16.5 billion takeover of Catalent (NYSE:), the contract drug manufacturer announced on Wednesday, days after the companies said all regulatory closing conditions were fulfilled.

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk (NYSE:), which makes the blockbuster GLP-1 injectable weight-loss drug Wegovy.

Source link

12/18/2024

Less than a minute